Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Conditions
- Adenocarcinoma of the Colon
- Adenocarcinoma of the Gallbladder
- Adenocarcinoma of the Pancreas
- Adenocarcinoma of the Rectum
- Adult Primary Hepatocellular Carcinoma
- Advanced Adult Primary Liver Cancer
- Cholangiocarcinoma of the Gallbladder
- Diffuse Adenocarcinoma of the Stomach
- Intestinal Adenocarcinoma of the Stomach
- Male Breast Cancer
- Mixed Adenocarcinoma of the Stomach
- Ovarian Endometrioid Adenocarcinoma
- Paget Disease of the Breast With Intraductal Carcinoma
- Paget Disease of the Breast With Invasive Ductal Carcinoma
- Recurrent Adult Primary Liver Cancer
- Recurrent Breast Cancer
- Recurrent Colon Cancer
- Recurrent Gallbladder Cancer
- Recurrent Gastric Cancer
- Recurrent Malignant Testicular Germ Cell Tumor
- Recurrent Pancreatic Cancer
- Recurrent Rectal Cancer
- Recurrent Salivary Gland Cancer
- Salivary Gland Adenocarcinoma
- Stage II Malignant Testicular Germ Cell Tumor
- Stage II Pancreatic Cancer
- Stage III Colon Cancer
- Stage III Gastric Cancer
- Stage III Malignant Testicular Germ Cell Tumor
- Stage III Pancreatic Cancer
- Stage III Rectal Cancer
- Stage III Salivary Gland Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IV Breast Cancer
- Stage IV Colon Cancer
- Stage IV Gastric Cancer
- Stage IV Pancreatic Cancer
- Stage IV Rectal Cancer
- Stage IV Salivary Gland Cancer
- Thyroid Gland Medullary Carcinoma
- Unresectable Gallbladder Cancer
Interventions
- BIOLOGICAL: recombinant fowlpox-CEA(6D)/TRICOM vaccine
- BIOLOGICAL: sargramostim
- BIOLOGICAL: recombinant fowlpox GM-CSF vaccine adjuvant
Sponsor
National Cancer Institute (NCI)